-
Type:
Change Request
-
Resolution: Persuasive
-
Priority:
Medium
-
FHIR Core (FHIR)
-
STU3
-
Biomedical Research & Regulation
-
STU
-
(NA)
-
-
Rik Smithies / Peter Bomberg: 20-0-0
-
Correction
-
Compatible, substantive
[This is for SubstancePolymer, which I can no longer locate]
The Scope should provide more detailed information at the molecular level of the substance, refering to the Scope of the MedicinalProduct resource. Maybe using the clinical research area (R&D) of the pharmaceutical laboratories may be helpful in order to have molecular information about substances.
- is voted on by
-
BALLOT-5270 Negative - Robert Hausam : 2018-May-FHIR R4
- Balloted